4.7 Article

Genotoxicity evaluation using primary hepatocytes isolated from rhesus macaque (Macaca mulatta)

期刊

TOXICOLOGY
卷 462, 期 -, 页码 -

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.tox.2021.152936

关键词

Non-human primate; Genotoxicity; Comet assay; Primary hepatocyte; Benchmark dose

资金

  1. U.S. Food and Drug Administration (FDA)
  2. National Center for Toxicological Research (NCTR) [E0770501]
  3. U.S. Department of Energy
  4. U.S. FDA

向作者/读者索取更多资源

Non-human primates (NHPs) have been crucial in various studies due to their physiological and genetic similarity to humans. This study isolated primary hepatocytes from rhesus macaques and compared their sensitivity and specificity in detecting genotoxic/carcinogenic compounds with primary human hepatocytes. Despite differences in CYP450 enzyme activities, the results showed that PMHs can be a reliable surrogate for PHHs in evaluating genotoxic hazards.
Non-human primates (NHPs) have played a vital role in fundamental, pre-clinical, and translational studies because of their high physiological and genetic similarity to humans. Here, we report a method to isolate primary hepatocytes from the livers of rhesus macaques (Macaca mulatta) after in situ whole liver perfusion. Isolated primary macaque hepatocytes (PMHs) were treated with various compounds known to have different pathways of genotoxicity/carcinogenicity and the resulting DNA damage was evaluated using the high-throughput CometChip assay. The comet data were quantified using benchmark dose (BMD) modeling and the BMD50 values for treatments of PMHs were compared with those generated from primary human hepatocytes (PHHs) in our previous study (Seo et al. Arch Toxicol 2020, 2207-2224). The results showed that despite varying CYP450 enzyme activities, PMHs had the same sensitivity and specificity as PHHs in detecting four indirect-acting (i.e., requiring metabolic activation) and seven direct-acting genotoxicants/carcinogens, as well as five non-carcinogens that are negative or equivocal for genotoxicity in vivo. The BMD50 estimates and their confidence intervals revealed species differences for DNA damage potency, especially for direct-acting compounds. The present study provides a practical method for maximizing the use of animal tissues by isolating primary hepatocytes from NHPs. Our data support the use of PMHs as a reliable surrogate of PHHs for evaluating the genotoxic hazards of chemical substances for humans.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据